PMID: 19481382
Question: Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?
Correct Answer: no

======================= Launch the MCC process =======================
PMID: 19481382
Question: Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
The core question is whether the Androgen Deficiency of Aging Men (ADAM) questionnaire is effective as a screening tool for Partial Androgen Deficiency of Aging Men (PADAM). Key information to look for includes the questionnaire's sensitivity, specificity, and overall diagnostic efficiency in identifying PADAM when compared to a gold standard measure (available testosterone levels).

**2. Evidence Evaluation**
The abstract reports that the ADAM questionnaire has a sensitivity of 83.3% but a very low specificity of 19.7% for detecting PADAM. This means that while the questionnaire is good at identifying those who may have the deficiency (few false negatives), it also incorrectly identifies a large number of men as having PADAM who do not (many false positives). Additionally, the overall diagnostic efficiency is described as low. In contrast, using only Item 1 of the questionnaire (decreased sexual desire) improves specificity to 66.7% while maintaining a reasonable sensitivity of 63.3%.

**3. Conclusion**
Given the high sensitivity but extremely low specificity of the ADAM questionnaire, its utility as a standalone screening tool is limited due to the high rate of false positives. The low diagnostic efficiency further suggests that it may not be reliable for effectively screening PADAM without additional confirmatory testing.

**4. Final Answer**
**My final choice is: "no"**
GPT selected: no

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether the ADAM questionnaire is useful for screening partial androgen deficiency of aging men (PADAM). Key information includes the study's methodology (cross-sectional, 96 men aged ≥40), the ADAM questionnaire's criteria for PADAM (positive items 1/7 or 3 other questions), and the gold standard (bioavailable testosterone <198.4 ng/dL). The critical data to evaluate are the ADAM questionnaire's sensitivity, specificity, and overall diagnostic efficiency for PADAM.

**2. Evidence Evaluation**  
- **Sensitivity and Specificity**: The ADAM questionnaire showed 83.3% sensitivity (good at detecting true positives) but only 19.7% specificity (poor at excluding false positives). Low specificity indicates many false positives, which is problematic for screening tools that aim to minimize over-identification.  
- **Prevalence vs. Actual Cases**: While 81.3% of men screened positive via ADAM, only 28.1% met the biochemical PADAM criteria (bioavailable testosterone <198.4 ng/dL). This large discrepancy suggests the ADAM questionnaire overestimates PADAM prevalence.  
- **Item-Level Performance**: Item 1 (decreased sexual desire) performed better than the full questionnaire (63.3% sensitivity, 66.7% specificity), but this does not redeem the overall tool's inefficiency.  
- **Conclusion from Abstract**: The authors explicitly state that the ADAM questionnaire has "low diagnostic efficiency," aligning with the poor specificity and high false-positive rate.  

**3. Conclusion**  
The ADAM questionnaire’s low specificity (19.7%) and high false-positive rate make it unreliable for screening PADAM. While it identifies many true cases (high sensitivity), it also incorrectly labels many men without biochemical PADAM as positive, which undermines its utility as a screening tool. The study's authors also concluded its inefficiency, supporting a "no" answer.

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether the ADAM questionnaire is useful for screening partial androgen deficiency (PADAM) in aging men. Key information to evaluate includes the tool’s sensitivity, specificity, and diagnostic accuracy compared to the biochemical gold standard (bioavailable testosterone <198.4 ng/dL).

**2. Evidence Evaluation**  
- The ADAM questionnaire identified 81.3% of participants as potential PADAM cases, but only 28.1% were confirmed via biochemical testing.  
- Sensitivity was **83.3%** (good for ruling out true cases), but specificity was **19.7%** (very poor at excluding non-cases, leading to high false positives).  
- The authors noted that individual symptoms (e.g., item 1: decreased sexual desire) outperformed the full questionnaire in specificity (66.7%) and sensitivity (63.3%).  
- The abstract concludes that the ADAM questionnaire has **low diagnostic efficiency** and suggests clinical suspicion of PADAM should prioritize symptoms like sexual dysfunction over the questionnaire.  

**3. Conclusion**  
While the ADAM questionnaire has high sensitivity, its extremely low specificity and poor agreement with biochemical confirmation indicate it is not reliable for screening. The authors explicitly state its low diagnostic utility. Thus, the answer is **"no."**

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

Initial consensus: All models selected no